Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Prospective Natural History Study of Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4

NCT04591483 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.

NCT NCT04591483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04591483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Prospective Natural History Study of Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4
Lead sponsor
National Eye Institute (NEI)
Phase
Observational
Overall status
Recruiting
Start date
April 19, 2022
Completion date
July 16, 2028
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stargardt-like macular dystrophy